|
November 05, 2026
TOP NEWS
Lenskart's net profit rose to Rs. 227 crore in the second an increase of about 123%. The eyewear
retailer's revenue grew 35.7% to ₹2,845 crore from ₹2,096 crore. (EBITDA)
climbed 50% to Rs. 621 crore in Q2FY27 from Rs. 414
crore a year ago in the same period. The EBITDA margin widened to 22% in the
second quarter from 20%.For the first half of the
year (H1FY27), Lenskart's revenue increased 33.0%
to Rs. 5,559 crore, while profit after tax reached
Rs. 461 crore, equivalent to 87% of the company's
full-year FY26 profit. Over the trailing 12 months, Lenskart's
revenue crossed Rs. 10,000 crore.
Shipping Corporation of India’s Q2FY27 :Shipping Corporation of India (SCI) reported a strong
performance in Q2FY27, with consolidated net profit rising 205% YoY to Rs.
578 crore, compared with Rs. 189 crore
in Q2FY26. Revenue from operations increased 71% YoY to Rs. 2,291 crore, while EBITDA nearly doubled to Rs. 982 crore.
Apollo Hospitals :
Hospital business revenue grows 23% as occupancy improves to 73%;
international patient revenue rises 37%; Apollo plans to add nearly 5,800
beds over five years. The company also announced "the completion of
divestment by Apollo Health and Lifestyle Ltd in Apollo Specialty Hospitals
Pvt Ltd and Apollo Fertility Centre Pvt Ltd.
Shringar House of Mangalsutra : The company
reported a 73% year-on-year increase in standalone net profit for 2QFY27. The
company posted a profit after tax of ₹394.72 million, compared to ₹228.49
million in the corresponding period last year. Alongside strong financials,
the company announced its strategic entry into the high-value bridal
jewellery segment. Revenue from operations surged 55% YoY to ₹8,186.62 million
in Q2FY27, up from ₹5,287.99 million in Q2FY26. EBITDA for Q2FY27 stood at
₹549 million, a substantial increase from ₹327 million in Q2FY26. The company
maintained its operational momentum in Q2, with strong growth in both revenue
and profit. EPS rose about 37% YoY to ₹4.09 in Q2FY27, from ₹2.99 in Q2FY26.
National Aluminium Co. Ltd.: The company
announced its quarterly results for the period ended September 2026 and H1 of
FY27. The revenue from operations for the quarter jumped 26% YoY to ₹5,419
crore, compared to ₹4,292 crore in the corresponding quarter of last year.
The growth was largely driven by robust production volumes during the
period. NALCO has achieved the highest-ever Aluminium Cast Metal
Production of 2.35 lakh tonnes for the first half of FY 2026–27. Similarly,
on the sales front, NALCO achieved its highest-ever cumulative domestic sales
of Alumina and metal in H1 FY 2026–27.
PhysicsWallah | Profit after tax (PAT) nearly doubled
year-on-year to ₹145.5 crore from ₹72.3 crore in the corresponding quarter
last year. Revenue increased 18.2% year-on-year to ₹1,242 crore from ₹1,051
crore. EBITDA rose 52.5% to ₹276 crore, compared with ₹181 crore in the
year-ago period. The EBITDA margin also expanded to 22.2% from 17.2%.
Nykaa | The firm reported a more than threefold
year-on-year increase in net profit to ₹101.2 crore in Q2 FY27, compared with
₹33 crore in the year-ago quarter. The company's beauty vertical reported a
gross merchandise value (GMV) of ₹4,454 crore during the quarter, covering
its e-commerce business, retail stores, eB2B distribution and House of Nykaa Beauty portfolio. Net sales value (NSV) grew 28%,
while EBITDA for the beauty vertical increased 51%.
Major decisions : Major decisions taken by Union Cabinet
- BESS: The Cabinet has approved a massive Rs
14,500 crore push to develop 92 GWh of energy storage capacity,
supporting an estimate of almost 1 lakh crore investment! Unique
features are: 60 GWh of pumped hydro storage. 30 GWh of battery energy
storage. 2 GWh through emerging technologies. 40% minimum domestic
content for battery storage projects. This would trigger a total
investment of Rs 1Lakh crore. Positive for Battery companies like Exide,
Amara raja, Waaree energies,
Premier Energies and BESS players.
- Critical Mineral: Capex Support Scheme to
promote Critical Mineral Processing with a financial outlay of Rs 2,814
crore for Lithium and Nickel processing approved. Will support critical
sectors of electric mobility, Battery Energy Storage System, electronics,
defence and speciality
steel. Positive for HEG, MOIL and NMDC.
MACRO UPDATE
- Macro
update: Loosing of Trump in the elections has came as Diwali bonus for the markets. Indian
equities markets are undergoing a rare mix of tailwinds with US
elections results favoring Indian markets, Fall
of crude prices, Yields cooling off, strong earnings season and Anti AI
trade etc. In the US elections, Democrats secured control of both
chambers of Congress, a major setback for Trump. This weakens his policy
agenda and lowers the odds of more tariff and geopolitical shocks.
Global money is also rotating out of crowded AI trades. Korea and
Taiwan, the AI heavyweights, fell 3.72% each on November 3 while the
Sensex gained 1.62%. The lesser exposure towards AI and semicon is now acting as boon to the Indian markets
- Macro’s are
also favoring the Indian markets US Treasury yields are falling, Brent
dropped about 6.5% to roughly $94/barrel, and the rupee firmed to around
94.80. Foreign buying has returned, with FIIs buying for a third
straight session, after prolonged selling. Over last 1
week FII’s have invested an total amount
of Rs 21,000 crores. Nifty at around 24,000 has de-rated from its all time highs
significantly and Q2 earnings have been resilient, so FII flows have
room to build. We prefer domestic demand plays (financials, consumption,
autos) and sectors that gain from lower crude. All the other major Asian
markets are trading deep negative with correction of 2-3% where as Gift Nifty
indicates a very strong gap up with 335 points on the bourses. Focus on
stocks which were thrashed due to high crude prices like Paints, Avaition, Chemicals and fertilizers etc and on the other side will be slightly negative
for Data center stocks as there is a global sell off in the AI
investments.
INVESTMENT CALL
BSE Ltd: Q2FY27 first cut - Volumes cool sequentially, margins hold firm
•
Revenue
grew 34.1% y-o-y to Rs 1,433 crore but fell 8.5% q-o-q, as index-options
ADPTV slipped 23.9% q-o-q to Rs 22,531 crore/day (still up 50.2% y-o-y).
•
Core
EBITDA rose 42.4% y-o-y to Rs 984 crore; margin improved to 68.7% from 64.7%
y-o-y and 68.4% q-o-q, as volume-linked costs fell along with revenue.
•
PAT grew
45% y-o-y to Rs 808 crore but was down 7.5% q-o-q on lower volumes and
investment income.
•
Volumes
have bounced back after the quarter, with October 2026 ADPTV hitting a record
Rs 35,481 crore/day; cash ADTV also hit a quarterly high of Rs 10,494 crore.
•
We have
BUY rating on the stock and will come out with detailed note shortly
|
Result Table (Consolidated)
|
|
|
|
|
Rs. cr
|
|
Particulars
|
Q2FY27
|
Q2FY26
|
Q1FY27
|
YoY
|
QoQ
|
|
Operating revenue
|
1,433
|
1,068
|
1,566
|
34.1%
|
-8.5%
|
|
Investments and
Deposits Income
|
118
|
71
|
141
|
65.7%
|
-16.2%
|
|
Other income
|
|
|
|
|
|
|
Total Income
|
1,551
|
1,140
|
1,707
|
36.1%
|
-9.2%
|
|
Total Expenses
|
449
|
378
|
494
|
18.8%
|
-9.2%
|
|
EBITDA
|
1,102
|
762
|
1,213
|
44.6%
|
-9.1%
|
|
Margins
|
71.1%
|
66.9%
|
71.1%
|
|
|
|
Core EBITDA
|
984.0
|
690.9
|
1071.9
|
42.4%
|
-8.2%
|
|
Margins
|
68.7%
|
64.7%
|
68.4%
|
|
|
|
Depreciation
|
46
|
32
|
43
|
41.9%
|
8.1%
|
|
SGF
|
11
|
11
|
26
|
|
-57.7%
|
|
Exceptional
|
|
|
|
|
|
|
PBT
|
1044.9
|
719.0
|
1144.1
|
45.3%
|
-8.7%
|
|
Share of Assoc./JV
|
28
|
20
|
20
|
37.5%
|
40.8%
|
|
Tax
|
265
|
182
|
291
|
45.6%
|
-9.0%
|
|
PAT
|
807.5
|
557.0
|
872.7
|
45.0%
|
-7.5%
|
|
PAT attributable to
non-controlling interest
|
-1.6
|
-1.4
|
-1.4
|
15.6%
|
19.9%
|
|
PAT attributable to
shareholders
|
809.2
|
558.4
|
874.0
|
44.9%
|
-7.4%
|
HUDCO Q2 FY27 Results: Net Profit Rises 28.3% to Rs. 911 Crore, Declares
₹1.35 Interim Dividend. has reported a 28.3% year-on-year (YoY)
increase in consolidated net profit to Rs. 911 crore for Q2 FY27), in line with estimates. NII below estimates
by 5% to Rs. 1166 crore , NII saw a sharp fall.
Though, Sharp improvement in asset quality: Improved to 0.71% at the end of
September 2026, down from 0.96% in the previous June quarter on resolution of
around 8-10 accounts in the last 6 months. The Board of Directors declared a
2nd interim dividend of ₹1.35 per equity share for FY27. Overall, a mix quarter.
First cut: Kirloskar
Oil Engines (Standalone) results – Meets Estimates
·
Revenues
for Q2FY27 was up by 19% yoy meeting our estimates
of 19% growth. B2B segment grew 20% YoY and B2C
sales were higher by 13%. Domestic Powergen saw
strong performance across LHP, MHP, and HHP segment, registering market
growth rates higher than competitors. MHP market share surged to record
numbers and there was significant uptick in HHP market share.
·
Operating
profit was lower by 6% as an impact of flat revenue growth. OPM declined by
300 bps. Reported PAT degrew by 14%.
·
Facility
at Sanand has been constructed.
·
View:
KOEL Q2FY25 performance had a
strong performance on the margins side. We shall review our earnings
estimates and come out with a detailed note post the conference call.
Currently we have a Buy rating on the stock.
Results (consolidated)
Rs
crore
|
Particulars
|
Q2FY27
|
Q2FY26
|
y-o-y (%)
|
Q1FY27
|
q-o-q (%)
|
|
Net sales
|
1,739
|
1,460
|
19.1
|
1,471
|
18.2
|
|
Operating profit
|
191
|
204
|
-6.3
|
165
|
15.5
|
|
Other income
|
10
|
12
|
-16.1
|
11
|
-9.3
|
|
Adjusted PAT (After MI)
|
115
|
133
|
-13.7
|
99
|
16.0
|
|
Adjusted EPS
|
8.0
|
9.2
|
-13.7
|
6.9
|
16.0
|
|
|
|
bps
|
|
bps
|
|
OPM (%)
|
11.0
|
14.0
|
-299
|
11.2
|
-26
|
|
NPM (%)
|
6.6
|
4.0
|
258
|
6.7
|
-13
|
|
Tax rate (%)
|
25.5
|
25.0
|
44
|
25.8
|
-29
|
Actual vs. estimates
Rs. Crore
|
Particulars
|
Q2FY27
|
Q2FY27E
|
Var %
|
|
Net Sales
|
1,739
|
1,722
|
1.0
|
|
Operating profit
|
191
|
215
|
-11.2
|
|
Adjusted PAT
|
115
|
138
|
-16.4
|
|
|
|
bps
|
|
OPM (%)
|
11.0
|
12.5
|
-151
|
|
NPM (%)
|
6.6
|
8.0
|
-138
|
First Cut: JK
Lakshmi Cement Q1 FY2027 (Standalone) Results – Weak Operating Performance;
Profit Declines Sharply
- Standalone revenue rose 5.6%
YoY to ₹1,617 crore, driven by volume growth and coming 2% ahead of our
estimates.
- Operating profit (EBITDA)
declined 25.9% YoY to ₹154 crore, 9% below our forecast, reflecting
pressure on margins.
- Cement sales volume increased
4.9% YoY; however, realisations remained flat YoY, while cost per tonne
increased 5.3% YoY, weighing on profitability. As a result, EBITDA per
tonne fell 29.7% YoY to ₹516.
- Net profit declined 75% YoY
to ₹21 crore, impacted by lower operating profitability and margin
pressure.
Standalone
|
Particulars
|
Q2FY27
|
Q2FY26
|
YoY
|
Q1FY27
|
QoQ
|
|
Net sales
|
1616.9
|
1531.8
|
5.6%
|
1904.8
|
-15.1%
|
|
Operating Profit
|
154.2
|
208.1
|
-25.9%
|
258.8
|
-40.4%
|
|
Adjusted PAT
|
20.9
|
82.3
|
-74.6%
|
106.8
|
-80.4%
|
|
EPS (Rs)
|
1.7
|
7.0
|
-76.0%
|
8.6
|
-80.4%
|
|
Margins (%)
|
|
|
BPS
|
|
BPS
|
|
OPM(%)
|
9.5%
|
13.6%
|
-405
|
13.6%
|
-405
|
|
NPM (%)
|
1.3%
|
5.4%
|
-408
|
5.6%
|
-431
|
|
Tax Rate (%)
|
28.0%
|
21.6%
|
648
|
23.7%
|
438
|
|
|
|
|
|
|
|
|
Volume million tonne
|
0.298300
|
0.2843
|
4.9%
|
0.36
|
-17.1%
|
|
Relization
|
5420.45
|
5387.86
|
0.6%
|
5294.0
|
2.4%
|
|
EBITDA/tonne
|
516.93
|
732.08
|
-29.4%
|
719.1
|
-28.1%
|
|
Particulars
|
Q2FY2027(A)
|
Q2FY2027(E)
|
Var %
|
|
Net sales
|
1616.9
|
1585.3
|
2%
|
|
Operating Profit
|
154.2
|
169.6
|
-9%
|
|
Adjusted PAT
|
20.9
|
39.6
|
-47%
|
|
EPS (Rs)
|
1.7
|
3.4
|
-50%
|
|
|
|
|
BPS
|
|
OPM(%)
|
9.5
|
10.7
|
-116
|
|
NPM (%)
|
1.3
|
2.5
|
-120
|
First cut Q2FY27: PI Industries - Disappointment Continues
- PI
Industries posted a massive miss with GPM down 779 bps YoY owing primarily
to higher input cost and unfavorable product mix.
- EBITDA
% were again a miss and were down 1,524 bps YoY .
higher employee cost and other overheads added to the margin squeeze.
- Global
pricing pressure and inventory destocking in agchem
exports is primarily keeping PI under pressure.
Pyroxa is facing pressure from generic Chinese
exports.
- We
have a HOLD on PI Industries. We have a concall on 5th Nov. We will come out with
a detailed note post that.
|
|
|
|
|
Rs.
Cr
|
|
Q2FY27
|
Q2FY26
|
Y-o-Y%
|
Q1FY27
|
Q-o-Q%
|
|
Net
Revenues
|
1,702
|
1,872
|
-9%
|
1,702
|
0%
|
|
Consumption
of Raw material
|
790
|
892
|
-11%
|
681.90
|
16%
|
|
Purchases
of stock-in-trade
|
75
|
82
|
-9%
|
42.30
|
77%
|
|
Increase
decrease in Stock
|
-
5
|
-
174
|
-97%
|
12.30
|
-137%
|
|
Gross
Profit
|
842
|
1,072
|
-21%
|
966
|
-13%
|
|
Gross
Margin
|
49.5%
|
57.3%
|
-779 bps
|
56.7%
|
-727 bps
|
|
Employee
Cost
|
257
|
221
|
16%
|
260.80
|
-2%
|
|
Other
Expenses
|
353
|
310
|
14%
|
337.60
|
4%
|
|
Total
Expenditure
|
1,469
|
1,331
|
10%
|
1,335
|
10%
|
|
EBITDA
|
233
|
541
|
-57%
|
367
|
-37%
|
|
EBITDA
margin
|
13.7%
|
28.9%
|
-1524 bps
|
21.6%
|
-791 bps
|
|
Other
Income
|
61
|
83
|
-26%
|
64
|
-5%
|
|
Interest
|
8
|
3
|
223%
|
7.90
|
6%
|
|
Depreciation
|
105
|
98
|
7%
|
103.70
|
1%
|
|
Pre-tax
profit
|
181
|
523
|
-66%
|
320
|
-66%
|
|
Tax
(Current)
|
45
|
114
|
-
|
73
|
-
|
|
Tax
(Deferred)
|
16
|
2
|
-
|
5
|
-
|
|
Total Tax
|
62
|
116
|
-
|
78
|
-
|
|
Reported
PAT - Consol
|
119
|
407
|
-71%
|
242
|
-51%
|
|
Extraordinary
Items
|
-
|
-
|
NM
|
-
|
NM
|
|
Share of
profit/(loss) of associate
|
4
|
2
|
-
|
2
|
-
|
|
Adjusted
PAT
|
122
|
409
|
-70%
|
244
|
-50%
|
Gujarat
Fluorochemicals : Q2 inline quarter; batteries to
power next growth run
Reco:
HOLD CMP: Rs 4,450
Target: Rs 5,000
- Q2 numbers were on-line,
driven by strong growth in fluoropolymers and fluorochemicals.
- Fluoropolymers continue to
benefit from increasing penetration of specialty grades and demand from
semiconductors, data centers and EVs, while
R32-led refrigerants growth remains strong with capacity utilisation is
expected to peak by Q3FY27.
- Near-term contribution is
expected to remain LiPF6-led, with electrolyte revenues likely from
H2FY28 and meaningful LFP contribution only from late FY28/FY29,
- Valuations already reflect a
significant portion of the medium-term opportunity. We maintain our HOLD
with a TP of Rs 5,000
|
|
|
|
Rs Cr
|
|
Particular
|
FY25A
|
FY26A
|
FY27E
|
FY28E
|
|
Revenue
|
4,737
|
4,996
|
6,798
|
8,305
|
|
EBITDA Margin%
|
24.4%
|
25.8%
|
27.1%
|
27.9%
|
|
Adjusted PAT
|
546
|
595
|
920
|
1,203
|
|
Y-o-y growth %
|
24.3%
|
9.0%
|
54.6%
|
30.7%
|
|
Adjusted EPS
|
49.7
|
54.2
|
83.7
|
109.5
|
|
P/E(x)
|
100.6
|
92.3
|
59.7
|
45.7
|
|
EV/EBITDA(x)
|
43.7
|
39.6
|
29.3
|
23.1
|
|
RoNW(%)
|
8.3
|
7.9
|
11.1
|
12.9
|
|
RoCE%
|
8.3
|
8.5
|
11.4
|
13.7
|
UPL
- Mixed bag Q2; all eyes on H2
Reco:
HOLD CMP: Rs 517
Target: Rs 580
- Revenue remained broadly flat
as the fall in volumes was offset by favourable forex conditions, while
EBITDA outperformed on cost optimization and better platform mix.
- An adverse weather and softer
demand weighed on volumes, while Advanta and SUPERFORM continued to
deliver strong growth and support earnings resilience.
- Management maintained its
FY27 guidance of 7-11% revenue growth and 10-14% EBITDA growth, implying
a stronger H2FY27 supported by seasonality, new launches and continued
momentum in growth platforms
- Despite improving
profitability, visibility on a sustained recovery in core crop
protection volumes remains limited. We maintain our HOLD rating with a target
price of Rs 580.
|
|
|
|
Rs Cr
|
|
Particular
|
FY25A
|
FY26A
|
FY27E
|
FY28E
|
|
Revenue
|
4,737
|
4,996
|
6,798
|
8,305
|
|
EBITDA Margin%
|
24.4%
|
25.8%
|
27.1%
|
27.9%
|
|
Adjusted PAT
|
546
|
595
|
920
|
1,203
|
|
Y-o-y growth %
|
24.3%
|
9.0%
|
54.6%
|
30.7%
|
|
Adjusted EPS
|
49.7
|
54.2
|
83.7
|
109.5
|
|
P/E(x)
|
100.6
|
92.3
|
59.7
|
45.7
|
|
EV/EBITDA(x)
|
43.7
|
39.6
|
29.3
|
23.1
|
|
RoNW(%)
|
8.3
|
7.9
|
11.1
|
12.9
|
|
RoCE%
|
8.3
|
8.5
|
11.4
|
13.7
|
OTHER NEWS
Krishna Institute of Medical Sciences
(KIMS): The company reported 11.9% year-on-year increase in consolidated net
profit to Rs.75 crore for the second quarter, compared with Rs.67 crore in
the corresponding period last year. Revenue from operations rose 39.9% to
Rs.1,344 crore from Rs.961 crore a year ago. EBITDA increased 27.5% to Rs.260
crore, compared with Rs.204 crore in the year-ago quarter. However, EBITDA
margin declined to 19.4% from 21.2%.
Aurobindo Pharma reported a 32.8%
year-on-year increase in consolidated net profit to ₹1,126 crore for the
second quarter of FY27, compared with ₹848 crore in the corresponding quarter
last year. The pharmaceutical company also reported its highest-ever
quarterly revenue from operations, supported by growth across its key
business segments.
|